Product Details

Mupirocin + Metronidazole 2% + 0.75% Cream delivers a high-quality topical combination therapy formulated to Indian Pharmacopoeia (IP) standards. This fixed-dose combination manages bacterial skin infections, combining broad-spectrum antibacterial and antiprotozoal-antibacterial action in a single topical preparation.

The cream combines:

• Mupirocin, a topical antibiotic that eliminates gram-positive bacterial skin infections by inhibiting bacterial protein synthesis through isoleucyl-tRNA synthetase inhibition, and
• Metronidazole, a nitroimidazole antibacterial and antiprotozoal agent that targets anaerobic bacteria by disrupting their DNA structure, extending coverage alongside Mupirocin.

Doctors commonly prescribe this combination for the treatment of bacterial skin infections, including those involving mixed aerobic and anaerobic organisms. Hospitals, clinics, and pharmacies rely on this formulation for its consistent quality and dependable results. Our manufacturing process follows strict quality standards to guarantee high purity, accurate dosing, and reliable therapeutic efficacy in every batch.

Key Features

• IP-standard compliant topical combination therapy
• Treats bacterial skin infections
• Delivers combined antibacterial and antiprotozoal-antibacterial action
• Contains Mupirocin 2% + Metronidazole 0.75%
• Maintains a high-purity, stable formulation
• Convenient 15 g tube for topical application
• Suits hospital, clinical, and pharmacy use